Alnylam Pharmaceuticals Inc. (ALNY) Stock Quote

Detailed Quote for Alnylam Pharmaceuticals Inc. (ALNY)

close 52 Week Information

52 Week High

February 6, 2012

Close: 13.25

52 Week Low

October 4, 2011

Close: 5.879

Today

Last Price
12.15

Change $
0.90

Change %
6.90%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
12.60

High
12.79

Low
11.72

Prev Close
13.05

Last Trade
2/10/12

Volume
724.36 k

52 Wk Hi
13.25

52 Wk Low
5.879

Market Cap
519.13 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
42,726,984

EPS (TTM)
-1.36

PE Ratio
N/A

close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange
NGS

News and Media for Alnylam Pharmaceuticals Inc. (ALNY)

Sector News | Topic News

News for ALNY

Fri, Feb 10, 2012

4:00 PM

Alnylam to Webcast Presentations at Upcoming Investor Conferences - Business Wire

Thu, Feb 09, 2012

4:00 PM

Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results - Business Wire

8:00 AM

Alnylam Scientists Discover Novel Method for Monitoring RNAi Activity in Blood Samples - Business Wire

Thu, Feb 02, 2012

4:00 PM

Alnylam to Webcast Conference Call Discussing Fourth Quarter and 2011 Financial Results - Business Wire

Mon, Jan 30, 2012

8:00 AM

Alnylam Receives Notice of Allowance from United States Patent and Trademark Office (USPTO) for New Patent Broadly Covering Second Generation Lipid Nanoparticles (LNP) for Systemic Delivery of RNAi Therapeutics - Business Wire

Thu, Jan 19, 2012

6:00 PM

Alnylam to Restructure Organization, Aligning Resources with Focus on Highest Value Pipeline Opportunities in "Alnylam 5x15(tm)" Product Strategy - Business Wire

Tue, Jan 17, 2012

9:08 AM

Alnylam Files Patent Infringement Suit Against Tekmira - Business Wire

Sun, Jan 08, 2012

4:00 PM

Alnylam Provides Key 2012 Goals for RNAi Therapeutics Pipeline - Business Wire

Fri, Jan 06, 2012

8:00 AM

Alnylam Files Clinical Trial Application for ALN-TTR02, an RNAi Therapeutic Targeting Transthyretin for the Treatment of Transthyretin-Mediated Amyloidosis - Business Wire

Thu, Jan 05, 2012

8:00 AM

Regulus Therapeutics to Present microRNA Platform and Pipeline Updates at Two Leading Scientific Conferences - PR Newswire

8:00 AM

Alnylam and Arrowhead Form Collaboration and Licensing Agreement - Business Wire

Wed, Jan 04, 2012

4:00 PM

Alnylam to Webcast Presentation at 30th Annual J.P. Morgan Healthcare Conference 2012 - Business Wire

6:00 AM

Alnylam Reports Positive Preliminary Clinical Results for ALN-PCS, an RNAi Therapeutic Targeting PCSK9 for the Treatment of Severe Hypercholesterolemia - Business Wire

Wed, Dec 28, 2011

8:00 AM

Alnylam Announces Publication of Pre-clinical Results with ALN-HTT, an RNAi Therapeutic for the Treatment of Huntington's Disease, in Experimental Neurology - Business Wire

Tue, Dec 13, 2011

8:00 AM

Alnylam Scientists Present New Data on RNAi Therapeutics at 53rd ASH Annual Meeting - Business Wire

Mon, Dec 12, 2011

8:00 AM

Regulus Therapeutics Initiates an Orphan and Rare Disease microRNA Therapeutic Effort in Brain Cancer - PR Newswire

Tue, Nov 29, 2011

8:00 AM

Alnylam Completes Enrollment in Phase IIb Study of ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection - Business Wire

Tue, Nov 22, 2011

4:00 PM

Alnylam to Webcast Presentation at the Piper Jaffray 23rd Annual Health Care Conference - Business Wire

Mon, Nov 21, 2011

6:00 AM

Alnylam Presents Positive Preliminary Clinical Results for ALN-TTR01, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis - Business Wire

Wed, Nov 16, 2011

4:00 PM

Alnylam Pharmaceuticals Grants InterfeRx(tm) Intellectual Property License to Sylentis for Development and Commercialization of RNAi Therapeutics - Business Wire

More News for ALNY >>

Tags for Alnylam Pharmaceuticals Inc.

Research stocks or mutual funds related to Alnylam Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to ALNY. The keywords below have been associated to ALNY by either user submission or electronic means.

rna silencing sirna library interfering rna pharmaceuticals careers endo pharmaceutical short rna shrna database double stranded rna sirna protocol pharmaceutical software pharma manufacturing antisense pharma license tuschl kv pharmaceutical company pharmaceutical sales pharma history of pharmaceuticals biotech corporation rnai screen pharmaceutical reports pharmaceutical magazine microrna Drugs small rna sirna synthesis pharmaceutical manufacturing software rnai knock down rnai design specialty pharmaceuticals sirna pool sirna plasmid sirna therapeutics pharmaceutical industry inducible rnai sirna sequence rna oligos rnai oligo silencing rnai hairpin sirna Healthcare bio pharmaceuticals rnai mouse pharmaceutical shrna mirna knockdown rnai Common Stock ambion rnai sirna mechanism